Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Receives $28.00 Average Price Target from Brokerages
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have been assigned a consensus rating of “Hold” from the four brokerages that are currently covering the stock, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average […]